1. Cellulitis statistics: http://content.nhiondemand.com/dse/consumer/HC2.asp?objID=100441&cType=hc

2. Maurer HR. Bromelain: biochemistry, pharmacology and medical use. Cell Mol Life Sci. 2001 Aug;58(9):1234-45.

3. Chandler, D.S., Mynott, T.L. Bromelain protects piglets from diarrhoea caused by oral challenge with K88 positive enterotoxigenic Escherichia coli. Gut 1998; 43(2): 196-202.

4. Wang, D., Wei, J., Hsu, K., Jau, J., Lieu, M.W., Chao, T.J., Chen, H.I. Effects of nitric oxide synthase inhibitors on systemic hypotension, cytokines and inducible nitric oxide synthase expression and lung injury following endotoxin administration in rats. J. Biomed. Sci. 1999 Jan; 6(1): 28-35.

5. Kirk, S.J., Hurson, M., Regan, M.C. et al. Arginine stimulates wound healing and immune function in elderly human beings. Surgery 1993 Aug; 114(2):155-9; discussion, 160.

6 Baligan M, Giardina A, Giovannini G, et al. L-arginine and immunity. Study of pediatric subjects. Minerva Pediatr. Nov1997;49(11):537-42.

7. Zeelie, J.J., McCarthy, T.J. Effects of copper and zinc ions on the germicidal properties of two popular pharmaceutical antiseptic agents, cetylpyridinium chloride and povidone-iodine. Analyst 1998; 123(3): 503-7. 

8. Dorman HJ, et al. Antimicrobial agents from plants: antibacterial activity of plant volatile oils. J Appl Microbiol. Feb2000;88(2):308-16.

9. Lamaison JL, et al. Medicinal Lamiaceae with antioxidant properties, a potential source of rosmarinic acid. Pharm Acta Helv. 1991;66(7):185-8.

10. Marino, M., Bersani, C., Comi, G. Impedance measurements to study the antimicrobial activity of essential oils from Lamiaceae and Compositae. Int. J. Food Microbiol. 2001 Aug 5; 67(3): 187-95.

11. Bhimani, R.S., Vendrov, Y., Furmanski, P. Influence of lactoferrin feeding and injection against systemic staphylococcal infections in mice. J. Appl. Microbiol. 1999 Jan; 86(1): 135-44.

12. Dial, E.J., Hall, L.R., Serna, H., Romero, J.J., Fox, J.G., Lichtenberger, L.M. Antibiotic properties of bovine lactoferrin on Helicobacter pylori. Dig. Dis. Sci. 1998 Dec; 43(12): 2750-6.

13. Haversen, L.A., Engberg, I., Baltzer, L., Dolphin, G., Hanson, L.A., Mattsby-Baltzer, Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice. Infect. Immun. 2000 Oct; 68(10): 5816-23.

14. Kuwata, H., Yip, T.T., Tomita, M., Hutchens, T.W. Direct evidence of the generation in human stomach of an antimicrobial peptide domain (lactoferricin) from ingested lactoferrin. Biochim. Biophys. Acta 1998 Dec 8; 1429(1): 129-41.

15. Kruzel, M.L., Harari, Y., Chen, C.Y., Castro, G.A. The gut. A key metabolic organ protected by lactoferrin during experimental systemic inflammation in mice. Adv. Exp. Med. Biol. 1998; 443: 167-73.

16. Saavedra, J.M. Clinical applications of probiotic agents. Am. J. Clin. Nutr. 2001 Jun; 73(6): 1147S-1151S.

17. Merck Manual eds, The Merck Manual of Diagnosis and Therapy, (Rahway,NJ: Merck & Co., Inc, 1997).

18. Life Extension eds., Disease Prevention and Treatment, 4th ed. Florida: Life Extension Media, 2003.

Return to Cellulitis Introduction